Ionis Pharmaceuticals IONS Available For Sale Securities Debt Maturities After Two Through Three And One Half Years Percentage
Available For Sale Securities Debt Maturities After Two Through Three And One Half Years Percentage at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughThreeAndOneHalfYearsPercentage.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's available for sale securities debt maturities after two through three and one half years percentage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's available for sale securities debt maturities after two through three and one half years percentage?
- Ionis Pharmaceuticals (IONS) reported available for sale securities debt maturities after two through three and one half years percentage of 6% in Q1 2026.
- How has Ionis Pharmaceuticals's available for sale securities debt maturities after two through three and one half years percentage changed year-over-year?
- Ionis Pharmaceuticals's available for sale securities debt maturities after two through three and one half years percentage decreased by 0.0% year-over-year, from 6% to 6%.
- What does available for sale securities debt maturities after two through three and one half years percentage mean?
- The portion of debt investments maturing between two and three and a half years.
- How do you interpret available for sale securities debt maturities after two through three and one half years percentage?
- A higher allocation here suggests a strategy focused on capturing higher yields over a longer duration, assuming a stable liquidity position.
- How does available for sale securities debt maturities after two through three and one half years percentage compare across companies?
- Commonly monitored by investors to understand the risk profile and yield strategy of corporate cash management.